Skip to Content

Continuing Education

2023 Year in Review Part 2: Bispecific Antibodies

Best Suited For: Pharmacist, Pharmacy Technician

CE Credits: 1 hours

Related Topics: New Drug Approvals, Bispecific Antibodies, Operational Challenges in Oncology Pharmacy

Description

The goal of this presentation is to educate pharmacy technicians, pharmacists, students, and residents about FDA approved bispecific antibodies in 2023. This presentation will provide a general overview of bispecific antibodies including unique adverse effects and their management. It will then discuss FDA approved indications, mechanism of action and dosing for bispecific antibodies approved in 2023. It will also briefly review the clinical trial data associated with their FDA approval, with a focus on safety and efficacy. Clinical and operational considerations will also be discussed.

Pricing

This activity does not require payment to register.

This course has expired.

View our full list of NCODA courses or check the webinar recordings for more to discover.